Completed NA INTERVENTIONAL 1-arm NCT05158842

Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study (Adult-bCPAP)

Optimising the Treatment of COVID-19 Positive/Negative Adults With Severe Pneumonia and/or ARDS in Bangladesh Using an Adaptive Version of Locally Made Bubble CPAP: Feasibility Study

Sponsor: Dhaka Medical College

Conditions Acute Respiratory Distress Syndrome Covid19 Severe Pneumonia

Interventions Adult bubble CPAP oxygen therapy device

Updated 5 times since 2022 Last updated: Aug 24, 2022 Started: Oct 8, 2021 Primary completion: Feb 17, 2022 Completion: Feb 17, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Respiratory Distress Syndrome and Covid19 and is currently completed. Dhaka Medical College leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Apr 2022 — Sep 2022 [monthly]

Recruiting NA
Jan 2022 — Apr 2022 [monthly]

Recruiting NA

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dhaka Medical College
International Centre for Diarrhoeal Disease Research, Bangladesh
University of Edinburgh

Data source: International Centre for Diarrhoeal Disease Research, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dhaka, Bangladesh